Cargando…
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker
The tyrosine kinase mesenchymal–epithelial transition (cMET) is typically overexpressed in up to 75% of patients with ovarian cancer, and cMET overexpression has been associated with poor prognosis. The proteolytic release of the soluble cMET (sMET) ectodomain by metalloproteases, a process called e...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410524/ https://www.ncbi.nlm.nih.gov/pubmed/33690968 http://dx.doi.org/10.1002/1878-0261.12939 |